Gene Therapy in Ophthalmology Market is Driven by Innovative Treatment Technologies
Gene therapy in ophthalmology involves the use of viral and non-viral vectors to deliver genetic material directly into ocular tissues, aiming to treat inherited retinal diseases, age-related macular degeneration (AMD), and other degenerative disorders of the eye. Key products include adeno-associated virus (AAV) vectors, lentiviral systems, and emerging CRISPR/Cas-based modalities, each...
0 التعليقات 0 المشاركات 101 مشاهدة 0 معاينة